SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: Cavalry who wrote (434)10/6/1998 9:51:00 AM
From: T-Lo Greens  Read Replies (2) | Respond to of 857
 
I think Mad and Doug both shorted HEB at $5 with a target of covering at $0. Everything I've read from unbiased sources in the medical annals and from the CDC suggest that HEB's numbers are correct, if not conservative, in estimating the potential market not only in the U.S. but worldwide. I wonder if Manure Ashitsio is still shorting?



To: Cavalry who wrote (434)10/6/1998 10:30:00 AM
From: Mad2  Read Replies (1) | Respond to of 857
 
When it's all said and done it will read like a soap opera. Anyone playing in HEB at this point (either way) needs be a bit carefull in the short term. Long term however Asensio isn't known for attacking credible companies. Credible companies are generally known for paying more attention to their business and less to their stock price. Have fun!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News